Skip to main content
. 2023 Apr 6;108(12):3278–3286. doi: 10.3324/haematol.2022.281788

Table 2.

Proportion of patients with additional intrathecal methotrexate in induction related to different initial patients' characteristics and (as assigned) type of Protocol IA.

graphic file with name 1083278.tab2.jpg